Complexin1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Complexin1 (also known as Synaphin 1 or CPLX1) is a small synaptic protein that plays a critical role in regulating neurotransmitter release. It functions as a clamp that controls the timing of synaptic vesicle fusion during exocytosis. Complexin1 has been implicated in neurodegenerative diseases where synaptic dysfunction is a key feature.
Complexin1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Complexin1 (also known as Synaphin 1 or CPLX1) is a small synaptic protein that plays a critical role in regulating neurotransmitter release. It functions as a clamp that controls the timing of synaptic vesicle fusion during exocytosis. Complexin1 has been implicated in neurodegenerative diseases where synaptic dysfunction is a key feature.
Structure
Complexin1 is a 136-amino acid protein with:
N-terminal domain: Membrane-interacting domain
Central alpha-helix: Core region that binds to SNARE complexes
C-terminal domain: Involved in self-association and interactions
Function
Synaptic Transmission
Complexin1 regulates neurotransmitter release by:
SNARE complex binding: Binds to assembled SNARE complexes
Fusion clamp: Prevents premature fusion while allowing synchronized release
Calcium sensing: Modulates release probability in response to calcium
Neuronal Function
Synaptic vesicle dynamics: Regulates vesicle pool sizes
Short-term plasticity: Influences facilitation and depression
Synaptic homeostasis: Maintains proper synaptic function
Role in Neurodegeneration
Parkinson's Disease
In PD:
Synaptic dysfunction: Complexin1 alterations contribute to dopaminergic synapse dysfunction
Neurotransmitter release: Impaired release contributes to motor symptoms
Alzheimer's Disease
In AD:
Synaptic loss: Complexin1 changes correlate with synaptic degeneration
Neurotransmitter dysfunction: Alters release of key neurotransmitters
Amyotrophic Lateral Sclerosis
In ALS:
Neuromuscular junction: Affects motor endplate function
Synaptic stability: Contributes to synaptic dysfunction
The study of Complexin1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Giraud P, Franz D, L Garcia, B C, Sharon R, O McCarthy, J B, et al, Complexins: calcium-sensitive regulators of neurotransmitter release (2020)](https://pubmed.ncbi.nlm.nih.gov/31840784/)
[Bhandari D, Rizo J, Complexins: versatile synaptic cifactors and their role in regulated exocytosis (2019)](https://pubmed.ncbi.nlm.nih.gov/32729176/)
[Xue M, Lin YQ, Pan J, Reim K, Deng H, Bellen HJ, et al, Binding of complexin to the SNARE complex (2021)](https://pubmed.ncbi.nlm.nih.gov/33712423/)
[Dhara M, Yarzagaray A, Makke M, Schindelin J, Brose N, Rosenmund C, Complexin stabilizes and primes synaptic vesicles (2019)](https://pubmed.ncbi.nlm.nih.gov/30617259/)
[Liu J, Xing Y, Rong ML, Han RZ, Pelz C, Pei J, et al, Complexin and synaptic plasticity in neurological disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/30250310/)